This increase in TXNIP was accompanied by elevated gene expression of NLRP3 and IL-1β, indicating that TXNIP promotes inflammation in T2DM through activation of the NLRP3 inflammasome (Szpigel et al., 2018). The gene discussed is TXNIP; the disease is type 2 diabetes mellitus.